Arzerra

ofatumumab · Novartis Pharmaceuticals

Drug timelines are a Plus or Pro feature.

15 regulatory and trial events tracked for Arzerra, covering 2011-07-20 to 2024-10-16. Get the full timeline:

Most recent: Clinical Trial Update: A Study of Idelalisib (GS1101, CAL101) + Ofatumumab in Previously Untreated CLL/SLL [Phase 2]